ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Baxalta Incorporated

Baxalta Incorporated (BXLT)

46.02
0.00
( 0.00% )
업데이트: 09:00:00

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
46.02
매수가
-
매도가
-
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
46.02
개장가
-
최근 거래 시간
마지막 거래 시간
-
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

BXLT 최신 뉴스

Shire Completes Combination With Baxalta Creating the Global Leader in Rare Diseases and Highly Specialized Conditions

Shire Completes Combination With Baxalta Creating the Global Leader in Rare Diseases and Highly Specialized Conditions PR Newswire DUBLIN, June 3, 2016 DUBLIN, June 3, 2016 /PRNewswire/...

TransDigm Group Set to Join the S&P 500; Helen of Troy and Brocade Communications Systems to Join S&P MidCap 400; Team and MD...

TransDigm Group Set to Join the S&P 500; Helen of Troy and Brocade Communications Systems to Join S&P MidCap 400; Team and MDC Holdings to Join S&P SmallCap 600 PR Newswire NEW YORK...

CORRECTING and REPLACING Baxalta Shareholders Vote to Approve Combination

First paragraph, second sentence of release should read: Baxalta shareholders approved the definitive merger agreement with Shire, dated as of January 11, 2016, and the merger transaction...

Baxalta Shareholders Vote to Approve Combination

Baxalta Incorporated (NYSE:BXLT) today announced the results of a vote on the proposals identified in the definitive proxy statement/prospectus, dated April 18, 2016, at a special meeting of...

OncoResponse Secures Investment from Baxalta

OncoResponse, an immuno-oncology antibody discovery company, today announced an investment from Baxalta Incorporated (NYSE: BXLT). In October 2015, OncoResponse closed a Series A financing...

Baxalta Reports Positive Phase 1 Results for BAX 930, Investigational Recombinant ADAMTS13 to Treat Hereditary Thrombotic Thr...

Single recombinant ADAMTS13 infusions demonstrated a favorable safety profile in adult and adolescent patients with severe hTTP hTTP is a rare blood clotting disease related to ADAMTS13...

Thunderbolt Pharma, Inc., a Vitesse Biologics Company, Acquires Rights to BAFF/APRIL Dual Antagonist Program from Astellas Ph...

First company established under Vitesse Biologics, an innovative collaboration formed by Baxalta, Mayo Clinic and Velocity Pharmaceutical Development Thunderbolt Pharma, Inc., will...

Baxalta Announces Preliminary Merger Consideration Election Results

Baxalta Incorporated (NYSE:BXLT) today announced the preliminary results of the elections made by its stockholders as to the form of stock consideration to be received in Baxalta’s merger...

Merrimack and Baxalta Announce Initiation of Phase 1 Study of MM-151 in Combination with the ONIVYDE® (irinotecan liposome i...

Merrimack and Baxalta Announce Initiation of Phase 1 Study of MM-151 in Combination with the ONIVYDE® (irinotecan liposome injection) Regimen in Metastatic Colorectal Cancer Study to evaluate...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

BXLT - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is US$ 46.02
What is the 1 year trading range for share price?
has traded in the range of US$ 0.00 to US$ 0.00 during the past year

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
TGITriumph Group Inc
US$ 25.165
(34.28%)
10.34M
MXMagnachip Semiconductor Corp
US$ 4.77
(17.78%)
1.01M
ALURAllurion Technologies Inc
US$ 6.4872
(10.33%)
293.27k
MYTEMYT Netherlands Parent BV
US$ 9.58
(8.00%)
106.08k
BODIBeachbody Company Inc
US$ 7.95
(7.29%)
29.28k
INRInfinity Natural Resources Inc
US$ 21.94
(-43.25%)
271.57k
ANVSAnnovis Bio Inc
US$ 3.40
(-30.18%)
1.73M
OMIOwens and Minor Inc
US$ 10.53
(-26.05%)
1.34M
PNSTPinstripes Holdings Inc
US$ 0.40
(-14.89%)
42.8k
SRIStoneridge Inc
US$ 4.56
(-11.80%)
116.23k
FFord Motor Company
US$ 9.9952
(-0.84%)
54.79M
QBTSD Wave Quantum Inc
US$ 5.715
(-3.79%)
28.22M
BTEBaytex Energy Corporation
US$ 2.3652
(-1.45%)
18.34M
NIONIO Inc
US$ 4.2202
(-2.31%)
17.8M
BBDBanco Bradesco SA
US$ 2.125
(0.71%)
17.27M
zab zab 5 분 전
Once again in the trump economy,  it's wise to just sit back and wait. Uncertainty is no way to run a company,  let alone America.  Two weeks in and again I feel bad for professionals like Air Traffic controllers and FBI agents, your job could be gone in a day. That's scary.
glenn1919 glenn1919 5 분 전
CLDI.......IVVD......CGBS........MGOL.........NVNI...................https://stockcharts.com/h-sc/ui?s=NVNI&p=D&yr=0&mn=3&dy=0&id=p11960084343
CGBS CLDI IVVD
budfoxfun budfoxfun 5 분 전
Collaboration of media with QVC and HSN (Home Shopping Network) with the support of Mann Media and Worldwide TV Products has the potential to generate millions of dollars in revenue, further reinforcing SGTM's commitment to sustainable growth.
SGTM
Stern is Bald Stern is Bald 5 분 전

FNMA
doogdilinger doogdilinger 5 분 전
ADIA stem cell play! 
ADIA
RIGATONI RIGATONI 5 분 전
Added ~Rig
Jefedejefes Jefedejefes 5 분 전
Put the crack pipe down and buy a HYLA vape so we can post a sale.
EDXC
shoondale shoondale 5 분 전
$MGON Beware eating this Regulation A garbage.
MGON
Stockexpertpro Stockexpertpro 5 분 전
ETHT Watch for a move back over 13$ Trump halts tarrifs on mexico meeting with canda today Bitcoin going green
BTCUSD
dewophile dewophile 6 분 전
More musings on Shionogi vs ENTA data
One likely difference between the two data sets is that ENTA was clearly at the top of the dose response curve, while Shionogi may not have been. ENTA had comparable viral responses in the two doses they disclosed, with the lower dose having 2% greater re
ENTA
declaes declaes 6 분 전
Thank you Bubae, You think I don't read the fillings? It is because I read the fillings that I invest in a stock.
I'm sure Mr. Leon CEO of GRST is also reading the fillings. And therefor is holding 54% of the outsatnding shares.
All you just posted, with your LINKS, is that GRST is fi
GRST
flipper44 flipper44 6 분 전
Nice post Danish Dude. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175751197

Ex and I had been arguing about spoofing events within an hour versus a minute or two a while back that I forgot our own magistrate had inferred all day in his previous R&R, and he apparen
NWBO
Mr Stock pick Mr Stock pick 6 분 전
ZERO shares available to short, no where but up from here
INBS
TenKay TenKay 6 분 전
“I will say before I go that you have the ability to go through every quarter and add up the debt that the company had so you can publicly prove me wrong.“

Items on a balance sheet are “balances”…you don’t add them up.

Is that what you were doing?
HMBL
Myth Myth 6 분 전
thanks, I'm on it !
glenngroove glenngroove 6 분 전
I'm surprise that some of the recent filings haven't sparked some interest in scooping cheap shares
LICH
Stevenvegas Stevenvegas 7 분 전
May hold VG for a bit. Doing well and still below IPO price.
manibiotech manibiotech 7 분 전
"By the way"
NWBO
RickNagra RickNagra 7 분 전
Oh wow.  Massive volume Varmit.  Whales have arrived as promised. $10 on deck.  Oh wow.  Oh boy oh girl.
GNCP
manibiotech manibiotech 7 분 전
And by the beat still drawing salary shamefully
NWBO
Stevenvegas Stevenvegas 8 분 전
The troops were already coming under Biden. So Mexico got things. Trump got existing. So the arsonists wants credit for trying to put out his fire. As always
doogdilinger doogdilinger 8 분 전
GM bb 
ADIA
CommodityCoverage CommodityCoverage 8 분 전
Allowing the company to proceed with its multi-center trial in France and the Netherlands, evaluating the safety, tolerability, and efficacy of TTI-0102 in 12 patients over six months, Thiogenesis Therapeutics (TTI.v) has received final regulatory clearance from the European Medicines Agency (EMA) t
TTI
loki loki 8 분 전
Second hole big success 
https://www.voxmarkets.co.uk/rns/announcement/29ca6d96-bce3-4db4-8416-7ac3bd2f1efb/
PSRHF

최근 히스토리

Delayed Upgrade Clock